In addition to glycemic control in type 2 diabetes (T2DM), clinical trial results and real-world experience support the use of sodium glucose-cotransporter 2 (SGLT2) inhibitors to prevent vascular events in patients with T2DM and established atherosclerotic cardiovascular disease. Moreover, SGLT2 inhibitors have shown significant efficacy for preventing the progression of diabetic nephropathy and heart failure hospitalizations. In this activity, Anne Peters, MD, discusses the role of SGLT2 inhibitors using an individualized approach to treatment that emphasizes shared decision-making and treatment goals beyond lowering A1C.
eNewsletter with interactive benchmarking and audio commentary
After completing this activity, participants should be better able to:
- Apply guideline recommendations and current evidence to individualize the use of SGLT2 inhibitors in appropriate patients with T2DM
- Summarize evidence for the benefits of SGLT2 inhibitors in patients with cardiovascular disease, heart failure, or renal disease
- Use shared decision-making with patients to develop strategies for the management of T2DM
NPs and PAs
Joint Accreditation Statement
In support of improving patient care, Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hours of pharmacology credit
Nurse planner: Jeffrey Kwong, DNP, MPH, ANP-BC, ACRN, Rutgers University, Newark, New Jersey
AAPA Credit Designation
Continuing Education Alliance has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until December 15, 2020. PAs should only claim credit commensurate with the extent of their participation.
PA planner: Lawrence Herman, MPA, PA-C, University of South Carolina School of Medicine, Columbia, South Carolina
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity is supported by an educational grant from Merck.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Continuing Education Alliance are required to disclose to the audience any relevant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Peters: advisory board: Abbott Diabetes Care, Bigfoot, Eli Lilly and Company, Livongo, MannKind, Mellitus Health, Novo Nordisk, Omada Health, Sanofi, Stability Health, Pendulum Therapeutics; grant/research support: Dexcom, vTv therapeutics; speaker: Novo Nordisk.
Dr Kwong: speaker: Gilead.
Mr Herman: consultant/speaker: Novo Nordisk.
Participants wishing to earn CE/CME credit must:
- Read the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hour.
Release date: December 15, 2019
Expiration date: December 15, 2020
© 2020 Practicing Clinicians Exchange. All Rights Reserved. 96819MPCE